The Importance of Community for Mental Health Struggles

Minaa B., a licensed mental health professional discusses her new book “Owning Our Struggles” an important book advocating for mental health inclusivity. She talks about how community-care is as important as self-care, cultural healing practices, building healthy relationships, holding yourself accountable, and healing parent-child relationships.

Read More

Luminelle – LUMINELLE SUSTAIN and the BX Sheath

Returning guest, Allison London Brown, CEO of LUMINELLE discusses LUMINELLE SUSTAINE endoscopic system and the recently FDA-cleared LUMINELLE Bx (Biopsy) RotoSheath of which she is a co-inventor. She talks about the uptick in the number of women diagnosed with uterine cancers due to the pandemic lockdown and certain procedures being considered elective. She shares her thoughts on the need for uterine screening in addition to mammograms and the disparity when it comes to women’s health.

Read More

Updated Results for ADCETRIS ® Immunotherapy Combination for Patients with Early-Stage Hodgkin Lymphoma

Dr. Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center and principal investigator of the study discusses the updated efficacy and safety data results for Seagen’s ADCETRIS ® (brentuximab vedotin) in combination with an immunotherapy-containing regimen. These data were presented at the 17th International Conference on Malignant Lymphoma (ICML).

Read More

​Medical Coding for Patients, Nurses, and Doctors

Rae Jimenez, Chief Product Officer at AAPC discusses medical coding and why it’s important for patients to know “what’s the code” prior to getting a surgery or procedure and how nurses and doctors can better advise their patients. Medical coding has also become a great career for many people allowing some to work from home.

Read More

Scout Clinical – Supporting Clinical Trials Through Patient Support

KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical, part of the Meeting Protocol Worldwide family, discusses Scout Clinical’s mission to help patients stay enrolled in clinical trials. On average, clinical trial participants must travel over 60 miles one way to visit clinical trial sites, contributing to just over half of all trials being terminated due to insufficient patient enrollment and retention.

Read More

New Insomnia Drugs Have the Potential to Reduce the Risk of Abuse and Overdose

Dr. David Neubauer, MD, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine discusses the current landscape of insomnia treatments and the petition for the DEA to de-schedule the Dual Orexin Receptor Antagonists (DORAs) class of insomnia medications which offer an entirely different approach to treating insomnia and meets an unmet need for longer-term use with little risk of dependence.

Read More

Vaxxinity – Expansively Disrupting Medicine

Mei Mei Hu, CEO of Vaxxinity, discusses the company’s approach to targeting a wide variety of chronic diseases such as Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia, as well as their COVID-19 booster vaccine. Vaxxinity aims to utilize its unique synthetic peptide platform technology to bring the convenience, efficiency, and cost-effectiveness of vaccines to the treatment and prevention of chronic diseases — making critical medicines available to all. For more information on Vaxxinity visit https://vaxxinity.com.

Read More